{"id":"W4403036158","doi":"10.1080/10428194.2024.2402814","title":"Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma","year":2024,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; AbbVie Canada; Pharmacyclics; GlaxoSmithKline; Pfizer","keywords":"Ibrutinib; Chronic lymphocytic leukemia; Medicine; Lymphoma; Internal medicine; Oncology; Leukemia","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001701206,0.002936947,0.003674402,0.003523622,0.0008948191,0.001108065,0.001370527,0.001526114,0.0002350273],"category_scores_gemma":[0.0003992046,0.002529701,0.001324581,0.005449746,0.001307853,0.001693144,0.0009579942,0.0006801815,0.0007327513],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.6244674,"about_ca_system_score_gemma":0.2028464,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03721309,"about_ca_topic_score_gemma":0.00229422,"domain_scores_codex":[0.9837715,0.000560897,0.003208006,0.004561923,0.003406435,0.004491242],"domain_scores_gemma":[0.9922887,0.001287863,0.0006447041,0.003237033,0.0004824722,0.002059195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02221682,0.001901468,0.1625819,0.01443885,0.00953045,0.03131007,0.008041684,0.008525841,0.00483513,0.007609243,0.008011381,0.7209972],"study_design_scores_gemma":[0.2888539,0.002746239,0.5209972,0.009125885,0.002789895,0.003998186,0.0008226188,0.144491,0.004818111,0.000714067,0.01489295,0.005749956],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782116,0.004995356,0.00006530247,0.000164181,0.002284923,0.003854974,0.00009831119,0.001903619,0.008421709],"genre_scores_gemma":[0.9840444,0.001491505,0.00115568,0.0005600842,0.001025306,0.0008137723,0.0006810476,0.0008910697,0.009337181],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7152473,"threshold_uncertainty_score":0.9999289,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01312591007018359,"score_gpt":0.2702881273349522,"score_spread":0.2571622172647686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}